The Hierarchy of Proinflammatory Cytokines in Ocular Inflammation
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
PURPOSE: The concept of tissue-dependent cytokine hierarchy has been demonstrated in a number of diseases, but it has not been investigated in ophthalmic diseases. Here, we evaluated the functional hierarchy of interleukin-1β (IL-1β), IL-6, IL-17A, and tumor necrosis factor (TNF) in the induction of ocular inflammation. MATERIALS AND METHODS: We delivered adeno-associated virus (AAV) vectors expressing IL-1β, IL-6, IL-17A, or TNF intravitreally in naïve C57/BL6 mice and compared and contrasted the inflammatory effects in the eye 5 weeks after AAV-mediated gene transfer. We also used an in vitro human system to test the effect of cytokines on barrier function. RESULTS: We found that IL-1β had the highest ability to initiate ocular inflammation. The continuous overexpression of IL-1β resulted in a significant upregulation of additional proinflammatory mediators in the eye. Using scanning laser ophthalmoscope and optical coherence tomography imaging techniques, we showed that a low dose of AAVIL-1β was sufficient and was as pathogenic as a high dose of TNF in inducing vascular leakage, retinal degeneration, and cellular infiltration. Furthermore, only a marginal increase in IL-1β was enough to cause cellular infiltration, thus confirming the highly pathogenic nature of IL-1β in the eye. Contrary to our expectation, IL-6 or IL-17A had minimal or no effect in the eye. To examine the clinical relevance of our findings, we used an impedance assay to show that IL-1β alone or TNF alone was able to cause primary human retinal endothelial cell barrier dysfunction in vitro. Again, IL-6 alone or IL-17A alone had no effect on barrier function; however, in the presence of IL-1β or TNF, IL-17A but not IL-6 may provide additive proinflammatory effects. CONCLUSIONS: Our studies demonstrate the existence of a functional hierarchy of proinflammatory cytokines in the eye, and we show that IL-1β is the most pathogenic when it is continuously expressed in the eye.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, retinal inflammation can induce local expression of pro-inflammatory cytokines and chemokines and can upregulate adhesion molecules on the basal RPE membrane, which leads to the recruitment of leukocytes and breakdown of the blood-retinal barrier.10,11”
From Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina (2021) · cites this paper as [11]
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Fanning, A. S., Jameson, B. J., Jesaitis, L. A., & Anderson, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29745 · Cited by 1,432
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811 · cited 1×
“IL-6 is a multifunctional, pleiotropic cytokine involved in hematopoiesis and inflammation.(15) IL-6 is secreted by T cells and macrophages to stimulate proinflammatory immune responses against infectious agents.”
BackgroundTherapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
International Journal of Cancer
(2006) · International Journal of Cancer · doi:10.1002/(issn)1097-0215 · Cited by 665
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
IL-1 stimulates IL-6 production in endothelial cells.
Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E., & Mantovani, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.549 · Cited by 521
Larsen, C. G., Anderson, A. O., Oppenheim, J. J., & Matsushima, K. (1989) · PubMed Central · Cited by 424
Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A. (2010) · Diabetes · doi:10.2337/db09-1606 · Cited by 403
Interleukin‐6 Gene‐Deficient Mice Show Impaired Defense against Pneumococcal Pneumonia
van der Poll, T., Keogh, C. V., Guirao, X., Buurman, W. A., Kopf, M., & Lowry, S. F. (1997) · The Journal of Infectious Diseases · doi:10.1086/514062 · Cited by 382
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
Goede, V., Brogelli, L., Ziche, M., & Augustin, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f · Cited by 319
Th17 T cells: Linking innate and adaptive immunity
Stockinger, B., Veldhoen, M., & Martin, B. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.008 · Cited by 271
Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy
Yuuki, T., Kanda, T., Kimura, Y., Kotajima, N., Tamura, J., Kobayashi, I., & Kishi, S. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00155-6 · Cited by 248
"The good, the bad, and the ugly." The role of chemokines in models of human disease
Strieter, R. M., Standiford, T. J., Huffnagle, G. B., Colletti, L. M., Lukacs, N. W., & Kunkel, S. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3583 · Cited by 244
Multiplex Bead Immunoassay Analysis of Aqueous Humor Reveals Distinct Cytokine Profiles In Uveitis
Curnow, S. J., Falciani, F., Durrani, O. M., Cheung, C. M. G., Ross, E. J., Wloka, K., Rauz, S., Wallace, G. R., Salmon, M., & Murray, P. I. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0444 · Cited by 222
Probert, L. (2000) · Brain · doi:10.1093/brain/123.10.2005 · Cited by 190
Zhou, J., Wang, S., & Xia, X. (2012) · Current Eye Research · doi:10.3109/02713683.2012.661114 · Cited by 170
Role of Interleukin-1β in the Development of Retinopathy in Rats: Effect of Antioxidants
Kowluru, R. A., & Odenbach, S. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0633 · Cited by 164
Cytokines and Chemokines in Uveitis - Is there a Correlation with Clinical Phenotype?
Ooi, K. G.-J., Galatowicz, G., Calder, V. L., & Lightman, S. L. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.4.294 · Cited by 152
Analysis of interleukin-6 in endotoxin-induced uveitis.
Hoekzema, R., Murray, P. I., Haren, M. A. C. V., Helle, M., & Kijlstra, A. (1991) · PubMed · Cited by 145
Liu, X., Ye, F., Xiong, H., Hu, D., Limb, G. A., Xie, T., Peng, L., Zhang, P., Wei, Y., Zhang, W., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.040 · Cited by 142
Self-citationChemokine-dependent mechanisms of leukocyte trafficking across a model of the blood–brain barrier
Eugenín, E. A., & Berman, J. W. (2003) · Methods · doi:10.1016/s1046-2023(02)00359-6 · Cited by 137
Multiplex Bead Analysis of Vitreous Humor of Patients with Vitreoretinal Disorders
Banerjee, S., Savant, V., Scott, R. A. H., Curnow, S. J., Wallace, G. R., & Murray, P. I. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-1358 · Cited by 128
RETINAL MORPHOLOGIC CHANGES AND CONCENTRATIONS OF CYTOKINES IN EYES WITH DIABETIC MACULAR EDEMA
Sonoda, S., Sakamoto, T., Yamashita, T., Shirasawa, M., Otsuka, H., & Sonoda, Y. (2013) · Retina · doi:10.1097/iae.0b013e3182a48917 · Cited by 114
TNF-α is an independent serum marker for proliferative retinopathy in type 1 diabetic patients
Gustavsson, C., Agardh, E., Bengtsson, B., & Agardh, C. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.03.001 · Cited by 100
Larsen, C. G., Zachariae, C. O. C., Oppenheim, J. J., & Matsushima, K. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80160-3 · Cited by 98
Takeuchi, M., Sato, T., Tanaka, A., Muraoka, T., Taguchi, M., Sakurai, Y., Karasawa, Y., & Ito, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137358 · Cited by 96
IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling
Qiu, A.-W., Bian, Z., Mao, P.-A., & Liu, Q.-H. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.117 · Cited by 86
Federici, S., Martini, A., & Gattorno, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00351 · Cited by 73
Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin
Fleisher, L. N., Ferrell, J., & McGahan, M. C. (1990) · Inflammation · doi:10.1007/bf00915816 · Cited by 73
Limb, G. A., Webster, L., Soomro, H., Janikoun, S., & Shilling, J. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.01067.x · Cited by 71
Bamforth, S. D., Lightman, S., & Greenwood, J. (1997) · Europe PMC (PubMed Central) · Cited by 57
Simultaneous Analysis of Multiple Cytokines in the Vitreous of Patients with Sarcoid Uveitis
Nagata, K., Maruyama, K., Uno, K., Shinomiya, K., Yoneda, K., Hamuro, J., Sugita, S., Yoshimura, T., Sonoda, K.-H., Mochizuki, M., et al. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-9244 · Cited by 54
LIMB, G. A., SOOMRO, H., JANIKOUN, S., HOLLIFIELD, R. D., & SHILLING, J. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00839.x · Cited by 49
Synergistic uveitic effects of tumor necrosis factor-alpha and interleukin-1 beta.
Fleisher, L. N., Ferrell, J., & McGahan, M. C. (1992) · PubMed · Cited by 38
Corneal epithelial cells produce thromboxane in response to interleukin 1 (IL-1).
Shams, N. B. K., Sigel, M. M., Davis, J. F., & Ferguson, J. G. (1986) · PubMed · Cited by 15
Research works printed but not linked: 6
- Shams NB, 1986, Invest Ophthalmol Vis Sci, 27, 1543
- 10.1086/jid.1997.176.issue-2 · doi:10.1086/jid.1997.176.issue-2
- Larsen CG, 1989, Immunol, 68, 31
- Fleisher LN, 1992, Invest Ophthalmol Vis Sci, 33, 2120
- Bamforth SD, 1997, Am J Pathol, 150, 329
- Hoekzema R, 1991, Invest Ophthalmol Vis Sci, 32, 88
Cited by
Wooff, Y., Man, S. M., Aggio-Bruce, R., Natoli, R., & Fernando, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01618 · Cited by 246
Ferreira, L. B., Williams, K. A., Best, G., Haydinger, C. D., & Smith, J. R. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1479 · Cited by 55
Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy
Tomkins‐Netzer, O., Niederer, R. L., Greenwood, J., Fabian, I. D., Serlin, Y., Friedman, A., & Lightman, S. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101245 · Cited by 47
Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
Chandler, L. C., McClements, M. E., Yusuf, I. H., Martinez-Fernandez de la Camara, C., MacLaren, R. E., & Xue, K. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.011 · Cited by 43
“leads to the recruitment of leukocytes and breakdown of the bloodretinal barrier.(10,11) We and others have shown that in vivo AAV subretinal injections induce the expression of pro-inflammatory cytokines and chemokines, including tumor necrosis factor-a (Tnf-a), interleukin-1b (Il-1b), and C-X-C motif chemokine ligan…”
BackgroundSantos, F. M., Ciordia, S., Mesquita, J., Sousa, J. P. C., Paradela, A., Tomaz, C. T., & Passarinha, L. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04670-y · Cited by 42
Metadata
- Authors
- Da Cunha, A. P., Zhang, Q., Prentiss, M., Wu, X. Q., Kainz, V., Xu, Y. Y., Vrouvlianis, J., Li, H., Rangaswamy, N., Leehy, B., McGee, T. L., Bell, C. L., Bigelow, C. E., Kansara, V., Medley, Q., Huang, Q., & Wu, H. Y.
- Affiliations
- Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
- Corresponding author
- Wu, H. Y.
- Venue
- Current Eye Research
- Publisher
- Informa UK Limited
- Published
- 2017-12-04
- Volume
- 43
- Issue
- 4
- Pages
- 553-565
- ISSN
- 0271-3683 (ISSN-L)
- 1460-2202
- OpenAlex
- W2771379188
- Cited by
- 40
- References
- 37
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 8 · 2020: 3 · 2019: 2 · 2018: 2
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Current Eye Research (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular inflammation, inflammatory cytokines, IL-1β, interleukin-6, IL-17A, TNF-α, AAV gene delivery, intravitreal delivery, vascular leakage, retinal degeneration, cell infiltration
- MeSH terms
- Animals, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Gene Expression Regulation, Inflammation, Male, Mice, Inbred C57BL, Endophthalmitis, Retinal Artery, RNA, Cytokines, Tomography, Optical Coherence, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.